RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
|Videos|November 23, 2016
How Are Immunization Recommendations Made?
Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, explains how immunization recommendations are made.
Advertisement
Gary Marshall, MD, professor of pediatrics at the University of Louisville School of Medicine, explains how immunization recommendations are made.
Advertisement
Related to this article
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit
2
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
3
Frontline Immunotherapy Options in NSCLC: Are Checkpoint Inhibitors Interchangeable?
4
Amivantamab Becomes First FDA-Approved Therapy in 10 Years for Pretreated Recurrent or Metastatic HNSCC
5